DTIL – Precision BioSciences, Inc.
Precision BioSciences, Inc.DTIL
$5.49Name : Precision BioSciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $60,874,216.00
EPSttm : -2.87
Precision BioSciences, Inc.
$5.49
7.02%$0.36Float Short %
21.76
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.03
EPS Last/This Y
-9.79
EPS This/Next Y
1.2
Price
5.39
Target Price
30.5
Analyst Recom
1
Performance Q
5.98
Relative Volume
2.2
Beta
1.46
Ticker: DTIL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-09 | DTIL | 5.19 | N/A | N/A | 0 |
| 2025-05-12 | DTIL | 5.23 | N/A | N/A | 0 |
| 2025-05-13 | DTIL | 5.17 | N/A | N/A | 0 |
| 2025-05-14 | DTIL | 4.96 | N/A | N/A | 0 |
| 2025-05-15 | DTIL | 4.55 | N/A | N/A | 0 |
| 2025-05-16 | DTIL | 4.65 | N/A | N/A | 0 |
| 2025-05-19 | DTIL | 4.67 | N/A | N/A | 0 |
| 2025-05-20 | DTIL | 4.87 | N/A | N/A | 0 |
| 2025-05-21 | DTIL | 4.58 | N/A | N/A | 0 |
| 2025-05-22 | DTIL | 4.6 | N/A | N/A | 0 |
| 2025-05-23 | DTIL | 4.55 | N/A | N/A | 0 |
| 2025-05-27 | DTIL | 4.92 | N/A | N/A | 0 |
| 2025-05-28 | DTIL | 4.94 | N/A | N/A | 0 |
| 2025-05-29 | DTIL | 4.92 | N/A | N/A | 0 |
| 2025-05-30 | DTIL | 4.82 | N/A | N/A | 0 |
| 2025-06-02 | DTIL | 5.04 | N/A | N/A | 0 |
| 2025-06-03 | DTIL | 5.1 | N/A | N/A | 0 |
| 2025-06-04 | DTIL | 5.15 | N/A | N/A | 0 |
| 2025-06-05 | DTIL | 5.19 | N/A | N/A | 0 |
| 2025-06-06 | DTIL | 5.27 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-09 | DTIL | 5.13 | - | - | -10.22 |
| 2025-05-12 | DTIL | 5.22 | - | - | -10.22 |
| 2025-05-13 | DTIL | 5.14 | - | - | -10.22 |
| 2025-05-14 | DTIL | 4.97 | - | - | -10.22 |
| 2025-05-15 | DTIL | 4.55 | - | - | -10.22 |
| 2025-05-16 | DTIL | 4.65 | - | - | -10.22 |
| 2025-05-19 | DTIL | 4.69 | - | - | -8.54 |
| 2025-05-20 | DTIL | 4.81 | -154.6 | - | -8.54 |
| 2025-05-21 | DTIL | 4.60 | -154.6 | - | -8.54 |
| 2025-05-22 | DTIL | 4.62 | -154.6 | - | -8.54 |
| 2025-05-23 | DTIL | 4.59 | -154.6 | - | -8.54 |
| 2025-05-27 | DTIL | 4.89 | -147.2 | - | -8.74 |
| 2025-05-28 | DTIL | 5.00 | -147.2 | - | -8.74 |
| 2025-05-29 | DTIL | 4.96 | -147.2 | - | -8.74 |
| 2025-05-30 | DTIL | 4.83 | -147.2 | - | -8.74 |
| 2025-06-02 | DTIL | 5.03 | -147.2 | - | -8.74 |
| 2025-06-03 | DTIL | 5.15 | -147.2 | - | -8.74 |
| 2025-06-04 | DTIL | 5.16 | -147.2 | - | -8.74 |
| 2025-06-05 | DTIL | 5.13 | -147.2 | - | -8.74 |
| 2025-06-06 | DTIL | 5.39 | -147.2 | - | -8.74 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-09 | DTIL | -1.11 | 22.77 | 21.96 |
| 2025-05-12 | DTIL | -2.84 | 19.90 | 22.45 |
| 2025-05-13 | DTIL | -2.84 | 19.90 | 22.45 |
| 2025-05-14 | DTIL | -1.11 | 19.90 | 22.45 |
| 2025-05-15 | DTIL | -1.11 | 19.90 | 22.45 |
| 2025-05-16 | DTIL | -1.11 | 19.90 | 22.45 |
| 2025-05-19 | DTIL | -1.06 | 9.64 | 22.45 |
| 2025-05-20 | DTIL | -1.06 | 9.64 | 22.45 |
| 2025-05-21 | DTIL | -1.06 | 9.64 | 22.45 |
| 2025-05-22 | DTIL | -1.16 | 9.64 | 22.45 |
| 2025-05-23 | DTIL | -1.16 | 9.64 | 22.45 |
| 2025-05-27 | DTIL | -1.16 | 11.67 | 22.45 |
| 2025-05-28 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-05-29 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-05-30 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-06-02 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-06-03 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-06-04 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-06-05 | DTIL | -1.16 | 11.67 | 21.76 |
| 2025-06-06 | DTIL | -1.16 | 11.67 | 21.76 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.21
Avg. EPS Est. Current Quarter
-2.21
Avg. EPS Est. Next Quarter
-2.24
Insider Transactions
-1.16
Institutional Transactions
11.67
Beta
1.46
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
28
Growth Score
40
Sentiment Score
23
Actual DrawDown %
98.9
Max Drawdown 5-Year %
-99.2
Target Price
30.5
P/E
Forward P/E
PEG
P/S
1.19
P/B
1.17
P/Free Cash Flow
EPS
-2.01
Average EPS Est. Cur. Y
-8.74
EPS Next Y. (Est.)
-7.55
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.99
Relative Volume
2.2
Return on Equity vs Sector %
-68.6
Return on Equity vs Industry %
-50.6
EPS 1 7Days Diff
1.5
EPS 1 30Days Diff
1.48
EBIT Estimation
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 107
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading